About Careers Internship MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Novel Gene Variants Identified in Male Breast Cancer

by Julia Samuel on March 2, 2016 at 9:18 PM
Font : A-A+

Novel Gene Variants Identified in Male Breast Cancer

Among cancer cases, male breast cancer (MBC) is a very rare tumor type, occurring in just 1% and the underlying genetic causes and treatment of MBC is not well understood.

In a paper published in the March issue of Cold Spring Harbor Molecular Case Studies, researchers from Italy and the U.S. describe novel genetic variants found in a hormone receptor positive (HR+) MBC patient, that are distinct from previously identified genetic variants found in ten MBC cases.

Advertisement


The authors present the treatment history of a HR+ male breast cancer patient. His disease stabilized from targeting of the PI3K/mTOR pathway using the PI3K/mTOR inhibitor BEZ235 in combination with everolimus as 3rd line treatment for his metastatic ductal carcinoma and experienced a prolonged stable disease.

After 18 months he subsequently became resistant to the treatment and his disease progressed. The authors then investigated why the patient benefited and subsequently developed resistance to this combination treatment using genomic and immunohistochemical analysis.
Advertisement

Whole-exome sequencing was performed on pre-treatment and post-progression samples of the MBC patient, as compared to a whole blood normal control. The researchers found that a region of Chromosome 12p was deleted in the resistant tumor and that HR protein expression was increased in the resistant tumor. This research provides new insights into both male breast cancer and response to BEZ235/everolimus combination treatment.

This study adds to our understanding of MBC development and resistance, and the authors commented that "Breast cancer in men is a very rare disease, representing less than 1% of all breast cancer cases. So, very few and small studies have been conducted in this disease. Our analyses contributed to delineate the genomic landscape of male breast cancer and suggested a potential particular benefit in this disease by the combined treatment with Afinitor plus BEZ235 in order to achieve a complete blockade of the PI3K/Akt/mTOR pathway. "

Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
Alarming Cesarean Section Trends in India - Convenience or Compulsion of Corporate Healthcare
Quiz on Low-Calorie Diet for Diabetes
World Heart Day in 2022- Use Heart for Every Heart
View all
Recommended Reading
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
DNA Finger Printing Mastitis Breasts - Structures and Types Breast Lumps Breast Lumps-Screening Weaver Syndrome Breast Enhancement Oil Gynecomastia How Do Viruses Mutate and Why Does it Matter? 

Most Popular on Medindia

Daily Calorie Requirements How to Reduce School Bag Weight - Simple Tips Blood Pressure Calculator Find a Doctor Hearing Loss Calculator Loram (2 mg) (Lorazepam) Drug - Food Interactions Pregnancy Confirmation Calculator Iron Intake Calculator Accident and Trauma Care
This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
×

Novel Gene Variants Identified in Male Breast Cancer Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests